Jump to ContentJump to Main Navigation
Evidence-based Public HealthEffectiveness and efficiency$
Users without a subscription are not able to see the full content.

Amanda Killoran and Mike P. Kelly

Print publication date: 2009

Print ISBN-13: 9780199563623

Published to Oxford Scholarship Online: February 2010

DOI: 10.1093/acprof:oso/9780199563623.001.0001

Show Summary Details
Page of

PRINTED FROM OXFORD SCHOLARSHIP ONLINE (www.oxfordscholarship.com). (c) Copyright Oxford University Press, 2019. All Rights Reserved. An individual user may print out a PDF of a single chapter of a monograph in OSO for personal use. date: 17 November 2019

Developing evidence-based guidance for health technologies: the NICE experience

Developing evidence-based guidance for health technologies: the NICE experience

Chapter:
(p.398) Chapter 27 Developing evidence-based guidance for health technologies: the NICE experience
Source:
Evidence-based Public Health
Author(s):

David Barnett,

Andrew Stevens,

Meindert Boysen,

Carole Longson

Publisher:
Oxford University Press
DOI:10.1093/acprof:oso/9780199563623.003.027

The National Institute for Health and Clinical Excellence (NICE) approach to appraisal of health care technologies was established in 1999 on the basis of three guiding principles: to provide guidance and standards to the National Health Service (NHS) based on clinical and cost-effectiveness of methods of treating ill health; to resolve uncertainty amongst both health care professionals and patients regarding the best approach to therapy; and consequently, to minimize inappropriate variation in clinical practice. The recipients of NICE guidance are primarily clinical professionals, commissioners of health care as well as the patients and carers that use the NHS. However, the ‘audience’ for NICE guidance also includes the manufacturers, the media, politicians, the general public, and the international community. This chapter provides an overview of the processes and methods used to appraise health care technologies, typically a new drug. It illustrates the appraisal of cost-effectiveness of health technologies using the ‘reference case’. It then highlights the role of ethical, legal, media, and political influences on the development of health technologies guidance.

Keywords:   Clinical Excellence, health care technologies, new drug evaluation, technologies guidance

Oxford Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us .